Type Distribution of Human Papillomavirus in Adult African Women Diagnosed With Invasive Cervical Cancer

GlaxoSmithKline (GSK)

Status: Completed

Conditions: Infections, Papillomavirus; Cervical Cancer

Treatments: Other: Data collection; Procedure: Collection of cervical cancer tissue samples

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT01207999

109117

Details and patient eligibility

About

The aim of the study is to assess the distribution of the most frequent types of human papillomavirus in African women diagnosed with invasive cervical cancer.

Enrollment: 591 patients

Sex: Female

Ages: 21+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• A female aged 21 years or more, presenting with a lesion macroscopically suggestive of invasive cervical cancer.
• Scheduled for cervical biopsy as per routine procedure at the participating institution on the day of the visit or on a later date.
• Written or oral-witnessed informed consent obtained from the subject prior to any study procedure.
• No prior chemo- or radiotherapy for cervical cancer.

Exclusion criteria

Not applicable

Trial design

591 participants in 1 patient group

Group A

Description:

Subjects diagnosed with invasive cervical cancer

Treatment:

Procedure: Collection of cervical cancer tissue samples

Other: Data collection